http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007075794-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79a2419692a6ddbd1392405c69b9befd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4201c10e2db578a4ae63997e5c8e2762
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6a2a3214798249cfb3f39f46fdb8b22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2006-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2614e12f7b1117cbc1f5250114483907
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2c2d509ee071233ebc83c7e11e1ddf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f37692260379e57b36ebaf34257fc45
publicationDate 2007-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007075794-A3
titleOfInvention Oral formulations comprising tigecycline
abstract Disclosed herein are pharmaceutical compositions comprising tigecycline for oral administration. The composition can comprise tigecycline having at least one enteric coating.
priorityDate 2005-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03005971-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0310814-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2414668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005148553-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54686904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57004235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23499812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128597033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129139087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73707446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136080371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247768374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66597886
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6207
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128225307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129979483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476913
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54575046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21756527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135778964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22178470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135883348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226476914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129130865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127722233

Total number of triples: 56.